D.E. Shaw & Co’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,592
Closed -$1.61M 3286
2025
Q1
$1.61M Sell
14,592
-14,118
-49% -$1.56M ﹤0.01% 1952
2024
Q4
$3.92M Sell
28,710
-140,744
-83% -$19.2M ﹤0.01% 1440
2024
Q3
$19.5M Buy
169,454
+61,076
+56% +$7.04M 0.02% 667
2024
Q2
$14.9M Sell
108,378
-36,902
-25% -$5.08M 0.01% 706
2024
Q1
$20M Buy
145,280
+69,278
+91% +$9.55M 0.02% 592
2023
Q4
$10M Buy
76,002
+16,940
+29% +$2.23M 0.01% 850
2023
Q3
$6.64M Sell
59,062
-181,422
-75% -$20.4M 0.01% 1028
2023
Q2
$22.7M Buy
240,484
+61,378
+34% +$5.79M 0.02% 516
2023
Q1
$18.1M Sell
179,106
-79,937
-31% -$8.09M 0.02% 641
2022
Q4
$30.9M Buy
259,043
+119,781
+86% +$14.3M 0.03% 407
2022
Q3
$14.8M Sell
139,262
-80,475
-37% -$8.55M 0.02% 701
2022
Q2
$21.4M Sell
219,737
-1,196
-0.5% -$117K 0.03% 571
2022
Q1
$20.7M Buy
220,933
+122,957
+125% +$11.5M 0.02% 680
2021
Q4
$8.35M Buy
+97,976
New +$8.35M 0.01% 1265
2021
Q2
Sell
-8,732
Closed -$849K 3678
2021
Q1
$849K Sell
8,732
-1,148
-12% -$112K ﹤0.01% 2269
2020
Q4
$947K Sell
9,880
-109,285
-92% -$10.5M ﹤0.01% 2048
2020
Q3
$11.5M Sell
119,165
-89,040
-43% -$8.56M 0.01% 838
2020
Q2
$25.4M Buy
208,205
+61,371
+42% +$7.49M 0.03% 489
2020
Q1
$12.7M Buy
146,834
+17,523
+14% +$1.52M 0.02% 664
2019
Q4
$13.9M Sell
129,311
-75,062
-37% -$8.07M 0.02% 718
2019
Q3
$18.4M Sell
204,373
-113,278
-36% -$10.2M 0.02% 599
2019
Q2
$26.8M Buy
317,651
+158,367
+99% +$13.4M 0.03% 476
2019
Q1
$14M Sell
159,284
-51,239
-24% -$4.51M 0.02% 690
2018
Q4
$15M Sell
210,523
-22,942
-10% -$1.64M 0.02% 631
2018
Q3
$28.7M Buy
233,465
+16,462
+8% +$2.02M 0.03% 457
2018
Q2
$21.3M Buy
217,003
+66,656
+44% +$6.55M 0.03% 537
2018
Q1
$12.5M Buy
150,347
+44,267
+42% +$3.67M 0.02% 684
2017
Q4
$8.23M Buy
106,080
+101,804
+2,381% +$7.9M 0.01% 851
2017
Q3
$262K Buy
+4,276
New +$262K ﹤0.01% 2272
2017
Q2
Sell
-22,114
Closed -$958K 2523
2017
Q1
$958K Sell
22,114
-147,281
-87% -$6.38M ﹤0.01% 1714
2016
Q4
$6.56M Sell
169,395
-12,276
-7% -$475K 0.01% 869
2016
Q3
$9.2M Buy
181,671
+146,220
+412% +$7.4M 0.02% 689
2016
Q2
$1.61M Buy
35,451
+6,541
+23% +$297K ﹤0.01% 1555
2016
Q1
$1.14M Sell
28,910
-284,557
-91% -$11.3M ﹤0.01% 1675
2015
Q4
$17.7M Sell
313,467
-161,085
-34% -$9.11M 0.03% 479
2015
Q3
$18.9M Buy
474,552
+227,951
+92% +$9.07M 0.03% 463
2015
Q2
$11.8M Sell
246,601
-50,691
-17% -$2.42M 0.02% 670
2015
Q1
$11.8M Sell
297,292
-72,178
-20% -$2.87M 0.02% 628
2014
Q4
$8.25M Buy
369,470
+73,568
+25% +$1.64M 0.01% 739
2014
Q3
$4.64M Buy
295,902
+172,408
+140% +$2.7M 0.01% 897
2014
Q2
$1.83M Buy
123,494
+75,895
+159% +$1.13M ﹤0.01% 1287
2014
Q1
$766K Buy
47,599
+20,599
+76% +$331K ﹤0.01% 1691
2013
Q4
$252K Buy
+27,000
New +$252K ﹤0.01% 2228
2013
Q3
Sell
-88,550
Closed -$1.19M 2501
2013
Q2
$1.19M Buy
+88,550
New +$1.19M ﹤0.01% 1433